UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

Evaluation of the inhibitory effect of quercetin on the pharmacokinetics of tucatinib in rats by a novel UPLC-MS/MS assay

Pharmaceutical biology, 2022-12, Vol.60 (1), p.621-626

2022

Volltextzugriff (PDF)

Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism

Chemico-biological interactions, 2024-04, Vol.392, p.110924-110924, Article 110924

2024

Volltextzugriff (PDF)

In vivo Pharmacokinetic Drug-Drug Interaction Studies Between Fedratinib and Antifungal Agents Based on a Newly Developed and Validated UPLC/MS-MS Method

Frontiers in pharmacology, 2021-02, Vol.11, p.626897

2021

Volltextzugriff (PDF)

Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice

Journal of affective disorders, 2019-02, Vol.245, p.939-949

2019

Volltextzugriff (PDF)

Bisphenol S stimulates Leydig cell proliferation but inhibits differentiation in pubertal male rats through multiple mechanisms

Environmental toxicology, 2023-10, Vol.38 (10), p.2361-2376

2023

Volltextzugriff (PDF)

Evaluation of herb-drug interaction of ambrisentan with shikonin based on UPLC-MS/MS

Pharmaceutical biology, 2021-01, Vol.59 (1), p.1131-1136

2021

Volltextzugriff (PDF)

Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo

Frontiers in pharmacology, 2023-05, Vol.14, p.1168852-1168852

2023

Volltextzugriff (PDF)

Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles

Pharmaceutical biology, 2022-12, Vol.60 (1), p.1-8

2022

Volltextzugriff (PDF)

CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism

Biomedicine & pharmacotherapy, 2024-06, Vol.175, p.116421, Article 116421

2024

Volltextzugriff (PDF)

A Reliable and Effective UPLC-MS/MS Method for the Determination of Oprozomib in Rat Plasma

Journal of analytical methods in chemistry, 2023-07, Vol.2023, p.3678599-6

2023

Volltextzugriff (PDF)

TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy‐proven nonalcoholic fatty liver disease

Journal of gastroenterology and hepatology, 2021-10, Vol.36 (10), p.2925-2934

2021

Volltextzugriff (PDF)

The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone

Biomedicine & pharmacotherapy, 2023-12, Vol.168, p.115833-115833, Article 115833

2023

Volltextzugriff (PDF)

Inhibitory effect of napabucasin on arbidol metabolism and its mechanism research

Frontiers in pharmacology, 2023-11, Vol.14, p.1292354-1292354

2023

Volltextzugriff (PDF)

Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro

Basic & clinical pharmacology & toxicology, 2018-04, Vol.122 (4), p.383-387

2018

Volltextzugriff (PDF)

Development of a UPLC-MS/MS method for the determination of lacosamide and its metabolite and its application to drug-drug interaction

Frontiers in pharmacology, 2023-11, Vol.14, p.1265252-1265252

2023

Volltextzugriff (PDF)

Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro

Fundamental & clinical pharmacology, 2022-02, Vol.36 (1), p.150-159

2022

Volltextzugriff (PDF)

Lack of pharmacokinetic interaction between derazantinib and naringin in rats

Pharmaceutical biology, 2023-12, Vol.61 (1), p.514-519

2023

Volltextzugriff (PDF)

Determination and Pharmacokinetic Profiles of Four Active Components From Scrophularia ningpoensis Hemsl. in Rats

Frontiers in pharmacology, 2021-01, Vol.11, p.612534

2021

Volltextzugriff (PDF)

Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro

Chemical research in toxicology, 2019-08, Vol.32 (8), p.1583-1590

2019

Volltextzugriff (PDF)

Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics

Frontiers in pharmacology, 2022-09, Vol.13, p.991281-991281

2022

Volltextzugriff (PDF)

Case Report of Neonatal Sotos Syndrome with a New Missense Mutation in the NSD1 Gene and Literature Analysis in the Chinese Han Population

Medicina (Kaunas, Lithuania), 2022-07, Vol.58 (7), p.968

2022

Volltextzugriff (PDF)

Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro

Journal of psychopharmacology (Oxford), 2021-12, Vol.35 (12), p.1517-1522

2021

Volltextzugriff (PDF)

Characterization of Alpelisib in Rat Plasma by a Newly Developed UPLC-MS/MS Method: Application to a Drug-Drug Interaction Study

Frontiers in pharmacology, 2021-11, Vol.12, p.743411-743411

2021

Volltextzugriff (PDF)

Effect of Sophocarpine on the Pharmacokinetics of Umbralisib in Rat Plasma Using a Novel UPLC-MS/MS Method

Frontiers in pharmacology, 2022-01, Vol.13, p.749095-749095

2022

Volltextzugriff (PDF)

A Novel UPLC-MS/MS Assay for the Measurement of Linezolid and its Metabolite PNU-142300 in Human Serum and its Application to Patients With Renal Insufficiency

Frontiers in pharmacology, 2021-05, Vol.12, p.641872-641872

2021

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Evaluation of the inhibitory effect of quercetin on the pharmacokinetics of tucatinib in rats by a novel UPLC-MS/MS assay

Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism

In vivo Pharmacokinetic Drug-Drug Interaction Studies Between Fedratinib and Antifungal Agents Based on a Newly Developed and Validated UPLC/MS-MS Method

Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice

Bisphenol S stimulates Leydig cell proliferation but inhibits differentiation in pubertal male rats through multiple mechanisms

Evaluation of herb-drug interaction of ambrisentan with shikonin based on UPLC-MS/MS

Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo

Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles

CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism

A Reliable and Effective UPLC-MS/MS Method for the Determination of Oprozomib in Rat Plasma

TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy‐proven nonalcoholic fatty liver disease

The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone

Inhibitory effect of napabucasin on arbidol metabolism and its mechanism research

Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro

Development of a UPLC-MS/MS method for the determination of lacosamide and its metabolite and its application to drug-drug interaction

Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro

Lack of pharmacokinetic interaction between derazantinib and naringin in rats

Determination and Pharmacokinetic Profiles of Four Active Components From Scrophularia ningpoensis Hemsl. in Rats

Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro

Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics

Case Report of Neonatal Sotos Syndrome with a New Missense Mutation in the NSD1 Gene and Literature Analysis in the Chinese Han Population

Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro

Characterization of Alpelisib in Rat Plasma by a Newly Developed UPLC-MS/MS Method: Application to a Drug-Drug Interaction Study

Effect of Sophocarpine on the Pharmacokinetics of Umbralisib in Rat Plasma Using a Novel UPLC-MS/MS Method

A Novel UPLC-MS/MS Assay for the Measurement of Linezolid and its Metabolite PNU-142300 in Human Serum and its Application to Patients With Renal Insufficiency

Suchergebnisse filtern